Wednesday May 8
Rigel Pharmaceuticals PT Lowered to $6.00
Shares of Rigel Pharmaceuticals traded up 3.20% during mid-day trading on Wednesday, hitting $4.67. Rigel Pharmaceuticals has a 52 week low of $4.41 and a 52 week high of $11.44. The stock's 50-day moving average is currently $6.16. The company's market cap is $406.9 million.
Rigel Pharmaceuticals (RIGL) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Rigel Pharmaceuticals posted its quarterly earnings results on Tuesday. The company reported earnings per share for the quarter, beating the analysts' consensus estimate of by $0.01, ARN reports.
Rigel Pharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! SOUTH SAN FRANCISCO, Calif., May 7, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
Market Maker Surveillance Report. SIRI, RIGL, S, GNW, AMD, ERIC,...
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday.
Rigel Pharmaceuticals PT Lowered to $7.00
The firm currently has an "outperform" rating on the stock. Rigel Pharmaceuticals opened at 4.50 on Monday.